[Treatment of venous thromboembolic disease in patients with cancer]. / Traitement de la maladie thromboembolique veineuse (MTE) chez les patients cancéreux.
Rev Med Interne
; 14(10): 1029, 1993.
Article
em Fr
| MEDLINE
| ID: mdl-8009025
ABSTRACT
Results of classical anticoagulant therapy in cancer patients with venous thromboembolism (VT) are highly discussed. We retrospectively analysed the outcome of 43 patients with VT and cancer 32% developed specific complications during either i.v. heparin therapy (10 +/- 0.9 days) or treatment by antivitamin K (106 +/- 14.9 days). Recurrence of thromboembolism (16%) and/or hemorrhages (16%) were much more frequent than in patients without cancer, underlying need for alternative therapy in cancer patients with VT.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tromboembolia
/
Neoplasias
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Fr
Revista:
Rev Med Interne
Ano de publicação:
1993
Tipo de documento:
Article